The COVID Shock To The Dollar
Can Novavax’s Huge Rally Continue? This 5-Star Analyst Sees 'Only' 25% Upside Ahead
J&J Fails To Overturn Baby Powder Verdict, Damages Cut To $2.12B
Lawmakers ask FDA to outline Covid-19 vaccine approval process
ETFMG launches ‘infectious diseases’ biotech ETF
Sanofi Adds COVID-19, Flu Candidates to up to $2.3B+ mRNA Vaccine Partnership with Translate Bio
Facebook tests Forecast, an app for making predictions about world events, like COVID-19
First COVID-19 vaccine trial in South Africa begins
Unicorns, Rainbows, & Fully-Invested Bears
GSK begins COVID-19 vaccine trial with Clover
Can people spread the coronavirus if they don't have symptoms? 5 questions answered about asymptomatic COVID-19
3 ways health tech is rising to the COVID challenge
Sanofi, Translate Bio Ramp Up Billion-Dollar mRNA Vaccine Collaboration
Simulations help reduce the effects of a second wave of COVID-19
Capsule’s video Q&A platform helps brands reach their community in the post-COVID era
US Open – Virus cases continue to surge, Risk-on drives dollar down, gold higher, Oil steadies
Evoke Pharma Pops 86% In Pre-Market On FDA Approval Of Gimoti Nasal Spray
Growth Over Graves Strategy Stress Tested
Gut reaction: How the gut microbiome may influence the severity of COVID-19
Moderna Leads the Pack With Its COVID-19 Vaccine, Says Top Analyst
The right way to breathe during the coronavirus pandemic
Coronavirus pandemic accelerating with Americas worst, warns WHO
US cities with pro sports see more flu deaths
China Shares New Evidence Blaming 'European Strain' For Beijing Outbreak, Germany Sees Concerning Spike In COVID-19 Cases: Live Updates
Boehringer Ingelheim nabs new US president and CEO; AstraZeneca vet hops aboard Novavax as CMO
Coronavirus pharma news roundup – 19/06/20
Near-term pullback, long-term uptrend
WHO hopes for hundreds of millions of vaccine doses this year, 2 billion next year
EU In Talks With Johnson & Johnson For Covid-19 Vaccine Deal
Emergent Makes $75 Million Investment To Boost Viral Vaccine Capabilities